Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fonds National de la Recherche Scientifique | OTHER |
Not provided
Not provided
Not provided
Not provided
The leading cause of death is cardiovascular diseases in occidental countries. Of those, atherosclerosis is the major contributor to this burden being notably responsible for strokes and myocardial infarctions. The genesis of atherosclerosis is linked to both lipid accumulation and inflammation in the vascular wall of major arteries. One of the major pathways of inflammation is the TGF-beta axis which is at least partially regulated by the GARP protein. It has been investigated mostly in cancer biology but data in cardiovascular disease is lacking. Thus, the investigators aim to characterize the contribution of this protein by investigating its expression in tissue from patients with atherosclerosis, the carotid or femoral plaque representing a good source of residual material adequate for research purpose. The main cells expressing the GARP protein are the platelets and the T regulating cells which will be the main focus.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Endarterectomy population | This group includes patients with significant atherosclerotic burden justifying a surgical intervention of carotid or femoral endarterectomy. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Tissue sample and data collection | Other | Tissue sample and data collection |
|
| Measure | Description | Time Frame |
|---|---|---|
| GARP Expression in Platelets | The number of cells/area expressing the GARP protein will be assessed | Throughout the entire study, approximately during 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| GARP Expression T Regulating Cells | The number of cells expressing GARP will be assessed as a number of cells / area | Throughout the entire study, approximately during 3 years |
| GARP Expression General |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
The study population will comprise patients undergoing femoral or carotid endarterectomy in our tertiary care center (Cliniques Universitaires Saint-Luc) for atherosclerotic disease who do not meet exclusion criteria.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Louis Charki, Medical Degree | Contact | +3224362014 | louis.charki@uclouvain.be |
| Name | Affiliation | Role |
|---|---|---|
| Christophe Beauloye, Medical Degree | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cliniques Universitaires Saint-Luc | Brussels | 1200 | Belgium |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002340 | Carotid Artery Diseases |
| D050197 | Atherosclerosis |
| D058226 | Plaque, Atherosclerotic |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D006650 | Histocompatibility Testing |
| D003625 | Data Collection |
| ID | Term |
|---|---|
| D007159 | Immunologic Tests |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
The plaques extracted from carotid or femoral endarterectomy will be used or all analysis.
The type of cells expressing GARP will be assessed as a number of cells / area
| Throughout the entire study, approximately during 3 years |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D001161 | Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D008919 | Investigative Techniques |
| D007158 | Immunologic Techniques |
| D004812 | Epidemiologic Methods |
| D017531 | Health Care Evaluation Mechanisms |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |